Committees

Lariam inquiry

Inquiry

Government response published

The Defence Committee's inquiry into the use of Lariam/Mefloquine in the UK Armed Forces.

Reports, special reports and government responses

View all reports and responses
4th Report - An acceptable risk? The use of Lariam by military personnel
Inquiry Lariam inquiry
Open PDF
Opens in new window
Open HTML
Opens in new window
HC 567
Report
Response to this report
3rd Special Report - An acceptable risk? The use of Lariam for military personnel: Government Response to the Committee’s Fourth Report of Session 2015–16
Open PDF
Opens in new window
Open HTML
Opens in new window
HC 648
Special Report
3rd Special Report - An acceptable risk? The use of Lariam for military personnel: Government Response to the Committee’s Fourth Report of Session 2015–16
Inquiry Lariam inquiry
Open PDF
Opens in new window
Open HTML
Opens in new window
HC 648
Special Report

Correspondence

View all correspondence
Letter, 8 September 2015, to Rt Hon Michael Fallon MP, Secretary of State for Defence concerning the use of Lariam by UK Armed Forces
Inquiry Lariam inquiry
Open PDF
Opens in new window
Correspondence
Response, 21 September 2015, from the Secretary of State, concerning the use of Lariam in UK Armed Forces
Inquiry Lariam inquiry
Open PDF
Opens in new window
Correspondence

Oral evidence transcripts

View all oral evidence transcripts
12 January 2016
Inquiry Lariam inquiry
Witnesses Mark Lancaster TD MP, Parliamentary Under-Secretary of State, Ministry of Defence, Vice Admiral Alasdair Walker OBE, Surgeon General of the Armed Forces, Brigadier Timothy Hodgetts CBE, Medical Director, Defence Medical Services, and Surgeon Captain John Sharpley, Defence Consultant in Psychiatry.
Open PDF
737KB
Open HTML
737KB
Oral Evidence
8 December 2015
Inquiry Lariam inquiry
Witnesses Dr Ashley Croft, Lieutenant Colonel (Retired) A G Marriott MBE, Trixie Foster, Dr Remington Nevin
Open PDF
735KB
Open HTML
735KB
Oral Evidence
10 November 2015
Inquiry Lariam inquiry
Witnesses Dr Frances Nichol, Head of Drug Safety and Quality and Mike Kindell, Lead, Established Products, Roche.
Open PDF
721KB
Open HTML
721KB
Oral Evidence

Written evidence

View all written evidence
Mrs Trixie Foster (LAR0028)
Open PDF
37KB
Open HTML
37KB
Ashley Croft and Remington Nevin (LAR0027)
Open PDF
2MB
Open HTML
2MB
Mr Lance Cole (LAR0019)
Open PDF
35KB
Open HTML
35KB

Other publications

No other publications published.

Contact us

  • Email: defcom@parliament.uk
  • Phone: 020 7219 3113 (general enquiries) | 020 7219 2996 (media enquiries)
  • Address: Defence Committee, House of Commons, London SW1A 0AA